NCT00793585View on ClinicalTrials.gov

A Controlled Study of Uric Acid on the Progression of IgA Nephropathy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
IgA Nephropathy
Interventions
DRUG

allopurinol

Patients will receive the lifestyle modification and treatment of allopurinol (300 mg /d) and lifestyle modification for 4 weeks; when the UA level \< 6mg/dl , the dosage changed to 200mg/d.

OTHER

continue their usual therapy

Patients will receive lifestyle modification and continue their usual therapy.

Trial Locations (1)

510080

The 1st Affiliated Hospital, Sun Yet-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT00793585 - A Controlled Study of Uric Acid on the Progression of IgA Nephropathy | Biotech Hunter | Biotech Hunter